BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15704188)

  • 1. Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study.
    Elbaz A; Peterson BJ; Bower JH; Yang P; Maraganore DM; McDonnell SK; Ahlskog JE; Rocca WA
    Mov Disord; 2005 Jun; 20(6):719-25. PubMed ID: 15704188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa-dyskinesia incidence by age of Parkinson's disease onset.
    Kumar N; Van Gerpen JA; Bower JH; Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):342-4. PubMed ID: 15580606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with levodopa and risk for malignant melanoma.
    Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
    Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid conditions associated with Parkinson's disease: a population-based study.
    Leibson CL; Maraganore DM; Bower JH; Ransom JE; O'brien PC; Rocca WA
    Mov Disord; 2006 Apr; 21(4):446-55. PubMed ID: 16161155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
    Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial aggregation of Parkinson's disease: The Mayo Clinic family study.
    Rocca WA; McDonnell SK; Strain KJ; Bower JH; Ahlskog JE; Elbaz A; Schaid DJ; Maraganore DM
    Ann Neurol; 2004 Oct; 56(4):495-502. PubMed ID: 15455403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education and occupations preceding Parkinson disease: a population-based case-control study.
    Frigerio R; Elbaz A; Sanft KR; Peterson BJ; Bower JH; Ahlskog JE; Grossardt BR; de Andrade M; Maraganore DM; Rocca WA
    Neurology; 2005 Nov; 65(10):1575-83. PubMed ID: 16301484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia.
    Melton LJ; Leibson CL; Achenbach SJ; Bower JH; Maraganore DM; Oberg AL; Rocca WA
    Mov Disord; 2006 Sep; 21(9):1361-7. PubMed ID: 16703587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.
    Kitzmann AS; Pulido JS; Diehl NN; Hodge DO; Burke JP
    Ophthalmology; 2008 Jan; 115(1):169-73. PubMed ID: 18166410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease.
    Rocca WA; Bower JH; Ahlskog JE; Elbaz A; Grossardt BR; McDonnell SK; Schaid DJ; Maraganore DM
    Mov Disord; 2007 Aug; 22(11):1607-14. PubMed ID: 17546668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture rates in Parkinson's disease compared with age- and gender-matched controls: a retrospective cohort study.
    Genever RW; Downes TW; Medcalf P
    Age Ageing; 2005 Jan; 34(1):21-4. PubMed ID: 15591480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of children and risk of Parkinson's disease.
    Frigerio R; Breteler MM; de Lau LM; Sanft KR; Bower JH; Ahlskog JE; Grossardt BR; ; Maraganore DM; Rocca WA
    Mov Disord; 2007 Apr; 22(5):632-9. PubMed ID: 17265462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark.
    Thomsen RW; Thomsen HF; Nørgaard M; Cetin K; McLaughlin JK; Tarone RE; Fryzek JP; Sørensen HT
    Cancer; 2008 Dec; 113(12):3410-9. PubMed ID: 18951518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the development of pedal edema in patients using pramipexole.
    Kleiner-Fisman G; Fisman DN
    Arch Neurol; 2007 Jun; 64(6):820-4. PubMed ID: 17420306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
    De Reuck J; De Weweire M; Van Maele G; Santens P
    J Neurol Sci; 2005 Apr; 231(1-2):35-9. PubMed ID: 15792818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant melanoma and other types of cancer preceding Parkinson disease.
    Olsen JH; Friis S; Frederiksen K
    Epidemiology; 2006 Sep; 17(5):582-7. PubMed ID: 16837822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
    Rosenquist K
    Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
    Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs associated with Parkinson's disease: a population-based study.
    Leibson CL; Long KH; Maraganore DM; Bower JH; Ransom JE; O'Brien PC; Rocca WA
    Mov Disord; 2006 Nov; 21(11):1864-71. PubMed ID: 16977632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.